Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuronz LtdfiledCriticalNeuronz Ltd
Priority to NZ510253ApriorityCriticalpatent/NZ510253A/en
Priority claimed from PCT/NZ1999/000147external-prioritypatent/WO2000013650A2/en
Publication of NZ510253ApublicationCriticalpatent/NZ510253A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
The neuroprotection and medicaments for use therein. Neuroprotection is induced by activation of neural growth hormone receptors, primarily using medicaments comprising growth hormone, functionally equivalent analogs of growth hormone or functionally equivalent ligands. Such medicaments may also include one or more neuroprotective agents.